Menu


Silver Sponsor


 

Glaukos Virtual Logo W Tagline Blk High ResCompany Profile – Glaukos

Glaukos (www.glaukos.com) is an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases.

The company pioneered Micro-Invasive Glaucoma Surgery, or MIGS, to revolutionize the traditional glaucoma treatment and management paradigm.

Glaukos launched the iStent®, its first MIGS device, in the United States in July 2012 and launched its next-generation iStent inject® device in the United States in September 2018.

In corneal health, Glaukos’ proprietary suite of single-use, bio-activated pharmaceuticals are designed to strengthen, stabilize and reshape the cornea through a process called corneal collagen cross-linking to treat corneal ectatic disorders and correct refractive conditions.

Glaukos is leveraging its platform technology to build a comprehensive and proprietary portfolio of micro-scale surgical and pharmaceutical therapies in glaucoma, corneal health and retinal disease.


Johnson & Johnson Vision

JJV Logo 1

 

 

 

 


Bronze Sponsor


 

legacyLegacy Benefits

 

After years of professional training to become a qualified specialist its vital that Ophthalmologists get the right advice to protect their future income potential. Let Legacy help evaluate the best options for you.

Legacy would like to offer a free, no obligation, review of your insurance needs - business and professional.

Please see our website for details of our services: http://www.legacygroup.co.nz/ and contact Simon Rupapera for a confidential discussion - DDI 09 354 5500, 

M 021 895 114   E simon.rupapera@legacygroup.co.nz

 


With Thanks


 

BuddleFindlaylogo 315x13ONZ would like to thank Buddle Findlay for the ongoing support that they give ONZ in their endeavours to assist members.